Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
› HRT: Update on the risk of breast cancer and long term safety
› Topical vaginal oestrogens: endometrial safety
› SSRI and venlafaxine in children
› Salmeterol (Severant) and formoterol (Oxis) in asthma management
› Methotrexate and pneumonitis
› Interaction between repaglinide (Novonorm) and gemfibrozil (Lopid)
› Sodium valproate and prescribing in pregnancy
› Reactions in humans to veterinary medicines
› Sibutramine (Reductil ): hypertension and tachycardia
› Pergolide (Celance) and cardiac valvulopathy
› Possible interaction between warfarin and cranberry juice
› Kava-kava and hepatoxicity
› Reminder: Gastrointestinal toxicity and NSAIDs
› Safety of thiomersal-containing vaccines
› Dopaminergic drugs and sudden sleep onset
› Yellow Card Scheme: your support is vital
Current Problems in Pharmacovigilance September 2003 
